RNXT
USDRenovoRx Inc. Common Stock
$1.020-0.050 (-4.673%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$1.070
High
$1.100
Low
$1.010
Volume
0.22M
Company Fundamentals
Market Cap
37.4M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.56M
Exchange
NCM
Currency
USD
52-Week Range
Low $0.75Current $1.020High $1.69
Related News
GlobeNewswire
RenovoRx CEO Shaun Bagai to Participate at the Canaccord Genuity MedTech, Diagnostics & Digital Health & Services Forum on November 20th
MOUNTAIN VIEW, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- RenovoRx, Inc. ("RenovoRx" or the "Company") (NASDAQ:RNXT), a life-sciences company developing innovative targeted oncology therapies and commercializing
View more
GlobeNewswire
RenovoRx to Host Third Quarter 2025 Financial Results and Business Highlights Conference Call on November 13th at 4:30 p.m. ET
MOUNTAIN VIEW, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) -- RenovoRx, Inc. ("RenovoRx" or the "Company") (NASDAQ:RNXT), a life sciences company developing innovative targeted oncology therapies and commercializing
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.